The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions
Open accessAbstract
Chronic active multiple sclerosis lesions, characterized by a hyperintense rim of iron-enriched, activated microglia and macrophages, have been linked to greater tissue damage. Post-mortem studies have determined that chronic active lesions are primarily related to the later stages of multiple sclerosis; however, the occurrence of these lesions, and their relationship to earlier disease stages may be greatly underestimated. Detection of chronic active lesions across the patient spectrum of multiple sclerosis requires a validated imaging tool to accurately identify lesions with persistent inflammation. Quantitative susceptibility mapping provides efficient in vivo quantification of susceptibility changes related to iron deposition and the potential to identify lesions harbouring iron-laden inflammatory cells. The PET tracer 11C-PK11195 targets the translocator protein expressed by activated microglia and infiltrating macrophages. Accordingly, this study aimed to validate that lesions with a hyperintense rim on quantitative susceptibility mapping from both relapsing and progressive patients demonstrate a higher level of innate immune activation as measured on 11C-PK11195 PET. Thirty patients were enrolled in this study, 24 patients had relapsing remitting multiple sclerosis, six had progressive multiple sclerosis, and all patients had concomitant MRI with a gradient echo sequence and PET with 11C-PK11195. A total of 406 chronic lesions were detected, and 43 chronic lesions with a hyperintense rim on quantitative susceptibility mapping were identified as rim+ lesions. Susceptibility (relative to CSF) was higher in rim+ (2.42 ± 17.45 ppb) compared to rim- lesions (-14.6 ± 19.3 ppb, P < 0.0001). Among rim+ lesions, susceptibility within the rim (20.04 ± 14.28 ppb) was significantly higher compared to the core (-5.49 ± 14.44 ppb, P < 0.0001), consistent with the presence of iron. In a mixed-effects model, 11C-PK11195 uptake, representing activated microglia/macrophages, was higher in rim+ lesions compared to rim- lesions (P = 0.015). Validating our in vivo imaging results, multiple sclerosis brain slabs were imaged with quantitative susceptibility mapping and processed for immunohistochemistry. These results showed a positive translocator protein signal throughout the expansive hyperintense border of rim+ lesions, which co-localized with iron containing CD68+ microglia and macrophages. In conclusion, this study provides evidence that suggests that a hyperintense rim on quantitative susceptibility measure within a chronic lesion is a correlate for persistent inflammatory activity and that these lesions can be identified in the relapsing patients. Utilizing quantitative susceptibility measure to differentiate chronic multiple sclerosis lesion subtypes, especially chronic active lesions, would provide a method to assess the impact of these lesions on disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This suggests that the TSPO PET signal arises from astrocytes as well as microglia, which is consistent with reports that newer generation ligands for TSPO bind to reactive astrocytes (Dickens et al., 2014; Kaunzner et al., 2019).”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Kaunzner et al., 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Similar to a recent study combining quantitative susceptibility mapping and immunohistochemistry (Kaunzner et al., 2019), our studies revealed non-trivial expression of TSPO in astrocytes in all subtypes of lesions examined.”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Kaunzner et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., HITZEMANN, R. J., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,481
Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker
Wang, Y., & Liu, T. (2015) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25358 · Cited by 878
Self-citationFrischer, J. M., Weigand, S. D., Guo, Y., Kale, N., Parisi, J. E., Pirko, I., Mandrekar, J., Bramow, S., Metz, I., Brück, W., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24497 · Cited by 728
de Rochefort, L., Liu, T., Kressler, B., Liu, J., Spincemaille, P., Lebon, V., Wu, J., & Wang, Y. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22187 · Cited by 672
Self-citationThe peripheral benzodiazepine binding site in the brain in multiple sclerosis
Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., et al. (2000) · Brain · doi:10.1093/brain/123.11.2321 · Cited by 661
Iron and neurodegeneration in the multiple sclerosis brain
Hametner, S., Wimmer, I., Haider, L., Pfeifenbring, S., Brück, W., & Lassmann, H. (2013) · Annals of Neurology · doi:10.1002/ana.23974 · Cited by 519
Quantitative MR Imaging of Brain Iron: A Postmortem Validation Study
Langkammer, C., Krebs, N., Goessler, W., Scheurer, E., Ebner, F., Yen, K., Fazekas, F., & Ropele, S. (2010) · Radiology · doi:10.1148/radiol.10100495 · Cited by 508
Cited by
Sorted by citations
Multiple sclerosis progression: time for a new mechanism-driven framework
Kuhlmann, T., Moccia, M., Coetzee, T., Cohen, J. A., Correale, J., Graves, J., Marrie, R. A., Montalban, X., Yong, V. W., Thompson, A. J., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00289-7 · Cited by 667
Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo
Absinta, M., Sati, P., Masuzzo, F., Nair, G., Sethi, V., Kolb, H., Ohayon, J., Wu, T., Cortese, I. C. M., & Reich, D. S. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2399 · Cited by 534
Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI
Dal‐Bianco, A., Grabner, G., Kronnerwetter, C., Weber, M., Kornek, B., Kasprian, G. J., Berger, T., Leutmezer, F., Rommer, P. S., Trattnig, S., et al. (2020) · Brain · doi:10.1093/brain/awaa436 · Cited by 230
Microglia in multiple sclerosis: Friend or foe
Guerrero, B. L., & Sicotte, N. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00374 · Cited by 215
Imaging chronic active lesions in multiple sclerosis: a consensus statement
Bagnato, F. R., Sati, P., Hemond, C. C., Elliott, C., Gauthier, S. A., Harrison, D. M., Mainero, C., Oh, J., Pitt, D., Shinohara, R. T., et al. (2024) · Brain · doi:10.1093/brain/awae013 · Cited by 207
Self-citationCellular sources of TSPO expression in healthy and diseased brain
Nutma, E., Ceyzériat, K., Amor, S., Tsartsalis, S., Millet, P., Owen, D. R., Papadopoulos, V., & Tournier, B. B. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05166-2 · Cited by 192
Bilgiç, B., Costagli, M., Chan, K., Duyn, J. H., Langkammer, C., Lee, J., Li, X., Liu, C., Marques, J. P., Milovic, C., et al. (2024) · Magnetic Resonance in Medicine · doi:10.1002/mrm.30006 · Cited by 160
Self-citationCerebral Iron Deposition in Neurodegeneration
Dušek, P., Hofer, T., Alexander, J., Roos, P. M., & Aaseth, J. (2022) · Biomolecules · doi:10.3390/biom12050714 · Cited by 170
A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis
Nutma, E., Stephenson, J. A., Gorter, R. P., de Bruin, J., Boucherie, D. M., Donat, C. K., Breur, M., van der Valk, P., Matthews, P. M., Owen, D. R., et al. (2019) · Brain · doi:10.1093/brain/awz287 · Cited by 138
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
Calabrese, M., Preziosa, P., Scalfari, A., Colato, E., Marastoni, D., Absinta, M., Battaglini, M., Stefano, N. D., Filippo, M. D., Hametner, S., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26913 · Cited by 115
Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis
Maggi, P., Kühle, J., Schädelin, S., van der Meer, F., Weigel, M., Galbusera, R., Mathias, A., Lu, P., Rahmanzadeh, R., Benkert, P., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012326 · Cited by 112
Scalfari, A., Traboulsee, A. L., Oh, J., Airas, L. M., Bittner, S., Calabrese, M., García‐Domínguez, J. M., Granziera, C., Greenberg, B. M., Hellwig, K., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27034 · Cited by 107
Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status
van der Weijden, C. W. J., Biondetti, E., Gutmann, I. W., Dijkstra, H., McKerchar, R., Faria, D. D. P., de Vries, E. F. J., Meilof, J. F., Dierckx, R., Prévost, V., et al. (2022) · Brain · doi:10.1093/brain/awac436 · Cited by 95
Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis
Meaton, I., AlTokhis, A. I., Allen, C. M., Clarke, M. A., Sinnecker, T., Meier, D., Enzinger, C., Calabrese, M., Stefano, N. D., Pitiot, A., et al. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585221118677 · Cited by 102
Nutma, E., Gebro, E., Marzin, M. C., van der Valk, P., Matthews, P. M., Owen, D. R., & Amor, S. (2021) · Glia · doi:10.1002/glia.24052 · Cited by 95
A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis
Rahmanzadeh, R., Galbusera, R., Lu, P., Bahn, E., Weigel, M., Baraković, M., Franz, J., Nguyen, T. D., Spincemaille, P., Schiavi, S., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26441 · Cited by 87
Self-citationLi, Z., Feng, R., Liu, Q., Feng, J., Lao, G., Zhang, M., Li, J., Zhang, Y., & Wei, H. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120148 · Cited by 84
QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions
Gillen, K. M., Mubarak, M., Park, C., Ponath, G. D., Zhang, S., Dimov, A., Levine-Ritterman, M., Toro, S., Huang, W., Amici, S. A., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51338 · Cited by 84
Self-citationCurrent and future role of MRI in the diagnosis and prognosis of multiple sclerosis
Rocca, M. A., Preziosa, P., Barkhof, F., Brownlee, W. J., Calabrese, M., Stefano, N. D., Granziera, C., Ropele, S., Toosy, A., Vidal‐Jordana, Á., et al. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.100978 · Cited by 94
In vivo imaging of chronic active lesions in multiple sclerosis
Calvi, A., Haider, L., Prados, F., Tur, C., Chard, D., & Barkhof, F. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520958589 · Cited by 89
Haacke, E. M., Chen, Y., Utriainen, D. T., Wu, B., Wang, Y., Xia, S., He, N., Zhang, C., Wang, X., Laganà, M. M., et al. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2019.09.006 · Cited by 73
Self-citationRole of Peripheral Immune Cells-Mediated Inflammation on the Process of Neurodegenerative Diseases
Yang, Q., Wang, G., & Zhang, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582825 · Cited by 73
Hamzaoui, M., Garcia, J., Boffa, G., Lazzarotto, A., Absinta, M., Ricigliano, V. A. G., Soulier, T., Tonietto, M., Gervais, P., Bissery, A., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26657 · Cited by 69
Elliott, C., Rudko, D. A., Arnold, D. L., Fetco, D., Elkady, A. M., Araújo, D., Zhu, B. Y., Gafson, A., Tian, Z., Belachew, S. M., et al. (2023) · Multiple Sclerosis Journal · doi:10.1177/13524585231162262 · Cited by 68
Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression
Treaba, C. A., Conti, A., Klawiter, E. C., Barletta, V. T., Herranz, E., Mehndiratta, A., Russo, A. W., Sloane, J. A., Kinkel, R. P., Toschi, N., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab134 · Cited by 62
Barquero, G., Rosa, F. L., Kebiri, H., Lu, P., Rahmanzadeh, R., Weigel, M., Fartaria, M. J., Kober, T., Théaudin, M., Pasquier, R. D., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102412 · Cited by 60
Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RIS
Oh, J., Suthiphosuwan, S., Sati, P., Absinta, M., Dewey, B. E., Guenette, M. D., Selchen, D. H., Bharatha, A., Donaldson, E., Reich, D. S., et al. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211002097 · Cited by 65
Immune mechanisms and shared immune targets in neurodegenerative diseases
Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 72
Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance
Dal‐Bianco, A., Oh, J., Sati, P., & Absinta, M. (2024) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864241306684 · Cited by 61
Zhang, S., Nguyen, T. D., Rúa, S. M. H., Kaunzner, U. W., Pandya, S., Kovanlikaya, I., Spincemaille, P., Wang, Y., & Gauthier, S. A. (2019) · Europe PMC (PubMed Central) · doi:10.3174/ajnr.a6071 · Cited by 58
Self-citationLang, N., Dick, J., Slynko, A., Schulz, C., Dimitrakopoulou‐Strauss, A., Sachpekidis, C., Enk, A., & Hassel, J. C. (2019) · Immunotherapy · doi:10.2217/imt-2018-0146 · Cited by 56
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?
Martire, M. S., Moiola, L., Rocca, M. A., Filippi, M., & Absinta, M. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2143265 · Cited by 60
Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis
Marcille, M., Rúa, S. M. H., Tyshkov, C., Jaywant, A., Comunale, J. P., Kaunzner, U. W., Nealon, N., Perumal, J. S., Zexter, L., Zinger, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08477-6 · Cited by 59
Self-citationDimethyl Fumarate Reduces Inflammation in Chronic Active Multiple Sclerosis Lesions
Zinger, N., Ponath, G., Sweeney, E., Nguyen, T. D., Lo, C. H., Diaz, I., Dimov, A., Teng, L., Zexter, L., Comunale, J., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001138 · Cited by 51
Self-citationBruschi, N., Boffa, G., & Inglese, M. (2020) · European Radiology Experimental · doi:10.1186/s41747-020-00186-x · Cited by 58
Nylund, M., Sucksdorff, M., Matilainen, M., Polvinen, E., Tuisku, J., & Airas, L. (2022) · Brain Communications · doi:10.1093/braincomms/fcab301 · Cited by 48
Blindenbacher, N., Brunner, E., Asseyer, S., Scheel, M., Siebert, N., Rasche, L., Bellmann–Strobl, J., Brandt, A. U., Ruprecht, K., Meier, D., et al. (2020) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217320915480 · Cited by 47
Long-term dynamics of multiple sclerosis iron rim lesions
Weber, C. E., Wittayer, M., Kraemer, M., Dabringhaus, A., Bail, K., Platten, M., Schirmer, L., Gass, A., & Eisele, P. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103340 · Cited by 43
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers
Bauckneht, M., Capitanio, S., Raffa, S., Roccatagliata, L., Pardini, M., Lapucci, C., Marini, C., Sambuceti, G., Inglese, M., Gallo, P., et al. (2019) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-019-0058-3 · Cited by 46
Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions
Elliott, C., Arnold, D. L., Chen, H., Ke, C., Zhu, L., Chang, I., Cahir-McFarland, E. D., Fisher, E., Zhu, B. Y., Gheuens, S., et al. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6742 · Cited by 43
From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions
Kolb, H., Al‐Louzi, O., Beck, E., Sati, P., Absinta, M., & Reich, D. S. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103194 · Cited by 44
Zhang, H., Nguyen, T. D., Zhang, J., Marcille, M., Spincemaille, P., Wang, Y., Gauthier, S. A., & Sweeney, E. M. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.102979 · Cited by 42
Self-citationChronic lesion activity and disability progression in secondary progressive multiple sclerosis
Beynon, V., George, I. C., Elliott, C., Arnold, D. L., Ke, J., Chen, H., Zhu, L., Ke, C., Giovannoni, G., Scaramozza, M., et al. (2022) · BMJ Neurology Open · doi:10.1136/bmjno-2021-000240 · Cited by 46
Gliosis and Neurodegenerative Diseases: The Role of PET and MR Imaging
Cavaliere, C., Tramontano, L., Fiorenza, D., Alfano, V., Aiello, M., & Salvatore, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00075 · Cited by 41
Multimodal comparisons of QSM and PET in neurodegeneration and aging
Cogswell, P. M., & Fan, A. P. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120068 · Cited by 38
Lou, C., Sati, P., Absinta, M., Clark, K. A., Dworkin, J. D., Valcarcel, A. M., Schindler, M. K., Reich, D. S., Sweeney, E. M., & Shinohara, R. T. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102796 · Cited by 38
TSPO-detectable chronic active lesions predict disease progression in multiple sclerosis
Polvinen, E., Matilainen, M., Nylund, M., Sucksdorff, M., & Airas, L. M. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200133 · Cited by 36
Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy
Bagnato, F. R., Gauthier, S. A., Laule, C., Moore, G. R. W., Bove, R. M., Cai, Z., Cohen‐Adad, J., Harrison, D. M., Klawiter, E. C., Morrow, S. A., et al. (2020) · Journal of Neuroimaging · doi:10.1111/jon.12700 · Cited by 37
Self-citationQuantitative susceptibility mapping shows lower brain iron content in children with autism
Tang, S., Xu, Y., Liu, X., Chen, Z., Zhou, Y., Nie, L., & He, L. (2020) · European Radiology · doi:10.1007/s00330-020-07267-w · Cited by 35
Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis
Nakamura, K., Thoomukuntla, B., Bena, J., Cohen, J. A., Fox, R. J., & Ontaneda, D. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585231224702 · Cited by 34
Dal‐Bianco, A., Schranzer, R., Grabner, G., Lanzinger, M., Kolbrink, S., Pußwald, G., Altmann, P., Ponleitner, M., Weber, M., Kornek, B., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.632749 · Cited by 37
Dimov, A., Li, J., Nguyen, T. D., Roberts, A., Spincemaille, P., Straub, S., Zun, Z., Prince, M. R., & Wang, Y. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28624 · Cited by 33
Self-citationPreziosa, P., Pagani, E., Moiola, L., Rodegher, M., Filippi, M., & Rocca, M. A. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520969105 · Cited by 33
Huang, W., Sweeney, E. M., Kaunzner, U. W., Wang, Y., Gauthier, S. A., & Nguyen, T. D. (2022) · Journal of Neuroimaging · doi:10.1111/jon.12987 · Cited by 33
Self-citationIron in multiple sclerosis – Neuropathology, immunology, and real-world considerations
Zierfuss, B., Wang, Z., Jackson, A. N., Moezzi, D., & Yong, V. W. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104934 · Cited by 34
CNS cell-derived exosome signatures as blood-based biomarkers of neurodegenerative diseases
Park, C., Weerakkody, J. S., Schneider, R., Miao, S., & Pitt, D. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1426700 · Cited by 35
Self-citationMatching ex vivo MRI With Iron Histology: Pearls and Pitfalls
De Barros, A., Arribarat, G., Combis, J., Chaynes, P., & Péran, P. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00068 · Cited by 31
MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis
Tavazzi, E., Zivadinov, R., Dwyer, M. G., Jakimovski, D., Singhal, T., Weinstock‐Guttman, B., & Bergsland, N. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1757435 · Cited by 33
Brain oxygen extraction fraction mapping in patients with multiple sclerosis
Cho, J., Nguyen, T. D., Huang, W., Sweeney, E. M., Luo, X., Kovanlıkaya, İ., Zhang, S., Gillen, K. M., Spincemaille, P., Gupta, A. K., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211048031 · Cited by 31
Self-citationTolaymat, B., Zheng, W., Chen, H. A., Choi, S., Li, X., & Harrison, D. M. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102317 · Cited by 31
Guo, R., Zhao, Y., Li, Y., Wang, T., Li, Y., Sutton, B. P., & Liang, Z. (2020) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28459 · Cited by 29
Spincemaille, P., Liu, Z., Zhang, S., Kovanlıkaya, İ., Ippoliti, M., Makowski, M. R., Watts, R., de Rochefort, L., Venkatraman, V. K., Desmond, P. M., et al. (2019) · Journal of Neuroimaging · doi:10.1111/jon.12658 · Cited by 28
Self-citationQuantitative susceptibility mapping in multiple sclerosis: A systematic review and meta-analysis
Voon, C. C., Wiltgen, T., Wiestler, B., Schlaeger, S., & Mühlau, M. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103598 · Cited by 31
Tozlu, C., Jamison, K. W., Nguyen, T. D., Zinger, N., Kaunzner, U. W., Pandya, S., Wang, Y., Gauthier, S. A., & Kuceyeski, A. F. (2021) · Brain and Behavior · doi:10.1002/brb3.2353 · Cited by 26
Self-citationDuque‐Wilckens, N., Teis, R., Sarno, E., Stölting, F., Khalid, S., Dairi, Z., Douma, A., Maradiaga, N. C., Hench, S., Dharshika, C., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.03.009 · Cited by 27
Rahmanzadeh, R., Weigel, M., Lu, P., Melie‐García, L., Nguyen, T. D., Cagol, A., Rosa, F. L., Baraković, M., Lutti, A., Wang, Y., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103177 · Cited by 29
Self-citationKhajetash, B., Talebi, A., Bagherpour, Z., Abbaspour, S., & Tavakoli, M. (2023) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/ace261 · Cited by 25
Central vein sign and iron rim in multiple sclerosis: ready for clinical use?
Preziosa, P., Rocca, M. A., & Filippi, M. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000946 · Cited by 26
Iron Rims as an Imaging Biomarker in MS: A Systematic Mapping Review
AlTokhis, A. I., Alotaibi, A., Felmban, G., Constantinescu, C. S., & Evangelou, N. (2020) · Diagnostics · doi:10.3390/diagnostics10110968 · Cited by 23
Diagnosis of Multiple Sclerosis
Oh, J. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001156 · Cited by 30
Regional microglial activation in the substantia nigra is linked with fatigue in MS
Singhal, T., Cicero, S., Pan, H., Carter, K., Dubey, S., Chu, R., Glanz, B. I., Hurwitz, S., Tauhid, S., Park, M., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000854 · Cited by 22
Kovbasyuk, Z., Tefera, E., Li, C., Baete, S. H., & Steriade, C. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03598-x · Cited by 23
Krajnc, N., Schmidbauer, V. U., Leinkauf, J., Haider, L., Bsteh, G., Kasprian, G. J., Leutmezer, F., Kornek, B., Rommer, P. S., Berger, T., et al. (2023) · Multiple Sclerosis Journal · doi:10.1177/13524585231197954 · Cited by 24
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis
Gelibter, S., Pisa, M., Croese, T., Finardi, A., Mandelli, A., Sangalli, F., Colombo, B., Martinelli, V., Comı, G., Filippi, M., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26154 · Cited by 19
TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy
Mahler, C., Schumacher, A.-M., Unterrainer, M., Kaiser, L., Höllbacher, T., Lindner, S., Havla, J. B., Ertl-Wagner, B. B., Patzig, M., Seelos, K., et al. (2021) · Brain · doi:10.1093/brain/awab127 · Cited by 20
Beyond McDonald: updated perspectives on MRI diagnosis of multiple sclerosis
Rovira, À., & Auger, C. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1957832 · Cited by 20
Smoldering lesions in MS: if you like it then you should put a rim on it
Pinto, C. M., Cambron, M., Dobai, A., Vanheule, E., & Casselman, J. W. (2021) · Neuroradiology · doi:10.1007/s00234-021-02800-0 · Cited by 20
Iron deposition in multiple sclerosis: overall load or distribution alteration?
Hamdy, E., Galeel, A. A., Ramadan, I., Gaber, D. E., Mustafa, H., & Mekky, J. F. (2022) · European Radiology Experimental · doi:10.1186/s41747-022-00279-9 · Cited by 19
Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?
Preziosa, P., Filippi, M., & Rocca, M. A. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1953983 · Cited by 19
New Imaging Markers in Multiple Sclerosis and Related Disorders
Hemond, C. C., Gaitán, M. I., Absinta, M., & Reich, D. S. (2024) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2024.03.004 · Cited by 18
The sequence of regional structural disconnectivity due to multiple sclerosis lesions
Tozlu, C., Olafson, E. R., Jamison, K. W., Demmon, E., Kaunzner, U. W., Marcille, M., Zinger, N., Michaelson, N. M., Safi, N., Nguyen, T. D., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad332 · Cited by 17
Self-citationApplication of Quantitative Magnetic Resonance Imaging in the Diagnosis of Autism in Children
Tang, S., Nie, L., Liu, X., Chen, Z., Zhou, Y., Pan, Z., & He, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.818404 · Cited by 17
Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study
Pitombeira, M. S., Koole, M. J. B., Campanholo, K. R., de Souza, A. B. P., Duran, F., Solla, D. J. F., Mendes, M. F., Apóstolos‐Pereira, S. L., Rimkus, C. D. M., Busatto, G. F., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05899-2 · Cited by 20
Frers, R. A. K., Losada, M. E. O., Kobiec, T., Udovin, L., Bertolino, M. L. A., Herrera, M. I., & Capani, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912005 · Cited by 17
Sudarshan, V. P., Li, S., Jamadar, S. D., Egan, G. F., Awate, S. P., & Chen, Z. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.117928 · Cited by 17
Tranfa, M., Cantoni, V., Green, R., Carignani, G., Capasso, S., Morra, V. B., Carotenuto, A., Cuocolo, A., Lanzillo, R., Moccia, M., et al. (2025) · Radiology · doi:10.1148/radiol.243718 · Cited by 16
Guo, Z., Long, L., Qiu, W., Lü, T., Zhang, L., Shu, Y., Zhang, K., Fang, L., & Chen, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.647519 · Cited by 17
Moog, T. M., McCreary, M., Wilson, A., Stanley, T., Yu, F. F., Pinho, M. C., Guo, X., & Okuda, D. T. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11089-9 · Cited by 17
Lehto, J., Nylund, M., Matilainen, M., Sucksdorff, M., Vuorimaa, A., Rajander, J., Wahlroos, S., Hariri, P., & Airas, L. M. (2023) · European Journal of Neurology · doi:10.1111/ene.15834 · Cited by 18
Microglia subtypes in acute, subacute, and chronic multiple sclerosis
Prineas, J. W., & Lee, S. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad046 · Cited by 16
Slowly expanding lesions are a marker of progressive MS – Yes
Absinta, M., & Dal‐Bianco, A. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211013748 · Cited by 16
Paramagnetic rim lesions are highly specific for multiple sclerosis in real-world data
Hemond, C. C., Dundamadappa, S. K., Deshpande, M., Baek, J., Brown, R. H., Ionete, C., & Reich, D. S. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf211 · Cited by 18
Estimation of Multiple Sclerosis lesion age on magnetic resonance imaging
Sweeney, E. M., Nguyen, T. D., Kuceyeski, A. F., Ryan, S., Zhang, S., Zexter, L., Wang, Y., & Gauthier, S. A. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117451 · Cited by 16
Self-citationShi, Z., Pan, Y., Yan, Z., Ding, S., Hu, H., Wei, Y., Luo, D., Xu, Y., Zhu, Q., & Li, Y. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104572 · Cited by 15
Concussion: Beyond the Cascade
Neumann, K. D., Broshek, D. K., Newman, B. T., Druzgal, T. J., Kundu, B. K., & Resch, J. E. (2023) · Cells · doi:10.3390/cells12172128 · Cited by 17
Rimkus, C. D. M., Otsuka, F. S., Nunes, D. M., Chaim, K. T., & Otaduy, M. C. G. (2024) · Diagnostics · doi:10.3390/diagnostics14131362 · Cited by 15
Three-dimensional MRI sequences in MS diagnosis and research
Hu, L., Rajendran, L., Lapointe, E., Tam, R. C., Li, D., Traboulsee, A. L., & Rauscher, A. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519848100 · Cited by 15
Klistorner, S., Barnett, M. H., Yiannikas, C., Barton, J., Parratt, J., You, Y., Graham, S. L., & Klistorner, A. I. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211033464 · Cited by 14
Chen, J., Zhang, Z., Nie, X., Xu, Y., Liu, C., Zhao, X., & Wang, Y. (2021) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-21-235 · Cited by 13
Self-citationGillen, K. M., Nguyen, T. D., Dimov, A., Kovanlıkaya, İ., Luu, H. M., Demmon, E., Markowitz, D. M., Bagnato, F. R., Pitt, D., Gauthier, S. A., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf011 · Cited by 14
Self-citation
Metadata
- Authors
- Kaunzner, U. W., Kang, Y., Zhang, S., Morris, E., Yao, Y., Pandya, S., Hurtado Rua, S. M., Park, C., Gillen, K. M., Nguyen, T. D., Wang, Y., Pitt, D., & Gauthier, S. A.
- Affiliations
- Weill Cornell Medicine (US)
- Cornell MRI Research Lab, New York City, NY, USA
- Department of Mathematics, College of Sciences and Health Professions, Cleveland State University, Cleveland, OH, USA
- Yale University (US)
- Corresponding author
- Gauthier, Susan A
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-12-15
- Volume
- 142
- Issue
- 1
- Pages
- 133-145
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6308309
- OpenAlex
- W2904004727
- Cited by
- 199
- References
- 63
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 40 · 2023: 27 · 2022: 33 · 2021: 30 · 2020: 23 · 2019: 11
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EngagedScholarship @ Cleveland State University (Cleveland State University) (submittedVersion)
- Funders
- National Institutes of Health (RO1 NS090464)
- Biogen (55000025)
- Genzyme (56585757)
- Novartis (56585786, UL1 TR000456-06)
- Weill Cornell Clinical and Translational Science Center
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- chronic active lesions, quantitative susceptibility mapping, [11C]PK11195, translocator protein (TSPO), microglial activation, macrophages, iron accumulation, innate immune activation, relapsing-remitting multiple sclerosis, progressive multiple sclerosis, CD68, immunohistochemistry
- MeSH terms
- CD68 Molecule, Adult, Aged, Brain, Carbon Radioisotopes, Chronic Disease, Cross-Sectional Studies, Female, Humans, Inflammation, Iron, Isoquinolines, Macrophages, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Retrospective Studies, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Microglia, Positron-Emission Tomography, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
